etidronate and pamidronate

etidronate has been researched along with pamidronate in 132 studies

Research

Studies (132)

Timeframe	Studies, this research(%)	All Research%
pre-1990	27 (20.45)	18.7374
1990's	54 (40.91)	18.2507
2000's	35 (26.52)	29.6817
2010's	14 (10.61)	24.3611
2020's	2 (1.52)	2.80

Authors

Authors	Studies
Martin, MB; Oldfield, E; Szabo, CM	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Guogas, LM; Lujan, SA; Matson, SW; Ragonese, H; Redinbo, MR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Lecouvey, M; Monteil, M; Puljula, E; Turhanen, P; Vepsäläinen, J; Weisell, J	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Almeida Paz, FA; Barbosa, JS; Braga, SS	1
Body, JJ	1
Sukhu, B; Tenenbaum, HC; Torontali, M	1
Gucalp, R; Keller, A; Mallette, LE; Neidhart, J; Richman, SP; Ritch, P; Sarma, PR; Siegel, R; Tauer, K; Wiernik, PH	1
Coleman, RE	1
Bauss, F; Bosies, E; Fleisch, H; Janner, M; Mühlbauer, RC; Schenk, R; Strein, K	1
Koiso, K; Miyagawa, I; Nemoto, R; Satou, S	1
Lockefeer, JH; Papapoulos, SE	1
Papapoulos, S	1
Blair, HC; Carano, A; Konsek, JD; Schlesinger, PH; Teitelbaum, SL	1
Grasser, W; Sato, M	1
Harada, M; Koiso, K; Miyakawa, I; Nemoto, R; Nishijima, Y; Sato, S	1
Boyle, IT; Gallacher, SJ; McKillop, JH; Patel, U	1
Koponen, HM; Mönkkönen, J; Ylitalo, P	1
Warrell, RP	1
Kuntz, D; Miravet, L	1
Kors, N; van Rooijen, N	1
Dandona, P; Khokher, MA	1
Ryan, WG	1
Boyle, IT; Cowan, RA; Dryburgh, FJ; Fraser, WD; Gallacher, SJ; Patel, U; Ralston, SH	1
Coleman, RE; Rubens, RD	1
Bijvoet, OL; Blanksma, HJ; Dahlinghaus-Nienhuys, PJ; Harinck, HI	1
Bijvoet, OL; Bloys van Treslong-de Groot, H; Boonekamp, PM; Löwik, CW; van de Pluym, G; van de Wee-Pals, L	1
Larsson, A; Lerner, UH	1
Simmelink, JW	1
Couchman, KG; Sheppeard, H	1
Maldague, B; Malghem, J	1
Anderson, DC; Cantrill, JA	1
Dodd, GW; Fraser, TR; Holdaway, IM; Ibbertson, HK; Wattie, D	1
Benedict, JJ; Levy, RJ; Linden, JA; Schoen, FJ; Webb, CL	1
Petrovic, AG; Stutzmann, JJ	1
Fleisch, H	1
Anderson, DC; Dewis, P; Prasad, BK; Willets, S	1
Bijvoet, OL; Cats, A; de Vries, E; Jager, MJ; Sleeboom, HP; van der Veen, CJ; van der Weij, JP; van Paassen, HC	1
Heath, DA; Mundy, GR; Wilkinson, R	1
Bornand, J; Edouard, C; Jung, A; Mermillod, B; Meunier, PJ	1
Delmas, PD; Meunier, PJ	1
Mautalen, CA	1
Dodd, G; Fraser, TR; Holdaway, IM; Ibbertson, HK; King, A; Rutland, M; Wattie, DJ	1
Bijvoet, OL; de Vries, E; Frijlink, WB; Jie, K; Meijer, CJ; Mulder, H; Reitsma, PH; te Velde, J; van der Linden, H; van der Wey, JP; van Paassen, HC	1
Aspen, AJ; Kramsch, DM; Rozler, LJ	1
Devogelaer, JP; Huaux, JP; Maldague, B; Malghem, J; Meersseman, F; Nagant de Deuxchaisnes, C; Rombouts-Lindemans, C; Withofs, H	1
Mazières, B	1
Rutland, MD	1
Dowhaniuk, M; Goziotis, A; Sukhu, B; Tenenbaum, HC; Torontali, M	1
Azuma, Y; Kiyoki, M; Ohta, T; Okabe, K; Oue, Y; Sato, H; Tsuchimoto, M	1
Siris, ES	1
Auriola, SO; Mönkkönen, J; Taskinen, M; Urtti, A	1
Hyvönen, PM; Kowolik, MJ	1
Kiełbiński, M	1
Gunasekera, RD; Wimalawansa, SJ	1
Hall, TG; Schaiff, RA	1
Collin, P; Fleisch, H; Guenther, HL; Martin, TJ; Sahni, M	1
Capozza, RF; Cointry, G; Delgado, CJ; Ferretti, JL; Montuori, E; Pérez Lloret, A; Roldán, E; Zanchetta, JR	1
Kinirons, MT	1
Hirsch, D; Levy, RJ; Schoen, FJ	1
Ralston, SH	1
Meunier, PJ; Vignot, E	1
Mönkkönen, J; Urtti, A; Ylitalo, P; Ylitalo, R	1
Ashley, S; Hanson, J; Kanis, JA; McCloskey, E; Paterson, AH; Powles, TJ	1
Löwik, C; Papapoulos, S; Que, I; Van Beek, E	1
Licata, AA	1
Body, JJ; Coleman, RE; Piccart, M	1
Breuer, E; Golomb, G; Klenner, T; Krempien, B; Mönkkönen, J; Ornoy, A; Patlas, N; Schlossman, A; Similä, J; Stadler, H; Van Gelder, JM	1
Berman, SK; Blank, MA; Ems, BL; Gibson, GW; Myers, WR; Phipps, RJ; Smith, PN	1
Fleisch, HA	1
Berenson, JR	2
Lipton, A	2
Ringe, JD	1
Brown, RJ; Löwik, CW; Papapoulos, SE; van Beek, E; Watts, DJ	1
Boyle, IT; Compston, J; Cooper, C; Eastell, R; Fogelman, I; Francis, RM; Hosking, DJ; Purdie, DW; Ralston, S; Reeve, J; Reid, DM; Russell, RG; Stevenson, JC	1
Azuma, Y; Kanatani, H; Kiyoki, M; Komoriya, K; Ohta, T; Oue, Y	1
Kautiainen, S; Luurila, S; Ylitalo, P; Ylitalo, R	2
Kalliovalkama, J; Kankaanranta, H; Lähteenmäki, T; Pörsti, I; Salenius, JP; Sisto, T; Wu, X; Ylitalo, P; Ylitalo, R	1
Pritzker, KP; Shinozaki, T; Takagishi, K; Watanabe, H	1
Knowles, S; Phillips, E; Shear, NH; Weber, E	1
Addesso, V; Lo, SH; Mancini, D; McMahon, DJ; Michler, RE; Rodino, MA; Seibel, MJ; Shane, E; Staron, RB	1
Musto, P	1
Mundy, GR	1
Bellido, T; Manolagas, SC; Parfitt, AM; Plotkin, LI; Roberson, PK; Weinstein, RS	1
Berenson, J; Hortobagyi, G; Lipton, A; Major, PP	1
MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC	1
Kanis, JA; McCloskey, EV	1
Blank, MA; Dierckman, TA; Gibson, GW; Myers, WR; Phipps, RJ; Smith, PN	1
Blank, MA; Gibson, GW; Lichtenberger, LM; Romero, JJ	1
Getz, B; Ingle, JN; Pederson, L; Reinholz, GG; Sanders, ES; Spelsberg, TC; Subramaniam, M	1
Papapoulos, SE	1
Bonabello, A; Bruzzese, T; Galmozzi, MR; Zara, GP	1
Watts, NB	1
Lortholary, A	1
Bukowski, JF; Das, H; Kamath, A; Wang, L	1
Bellido, T; Leoni, J; Mathov, I; Plotkin, LI; Sgarlata, CL	1
Wiffen, PJ; Wong, R	1
Arsura, EL; Caldwell, JW; Johnson, RH; Kilgore, WB; Reddy, CM	1
Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R	1
Khuri, F; Saba, N	1
Abrahamsen, B; Brixen, KT; Kassem, MS; Mosekilde, L	1
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP	1
Orcel, P; Rousière, M	1
Franke, HR; Verdijk, R; Vermes, I; Wolbers, F	1
Aerts, K; Bridts, CH; Cos, P; De Clerck, LS; De Tollenaere, CB; Dombrecht, EJ; Ebo, DG; Schuerwegh, AJ; Stevens, WJ; Van Offel, JF	1
Langdahl, B; Mosekilde, L; Vestergaard, P	1
Dulea, C; Gherase, A; Savu, SR; Silvestro, L; Tarcomnicu, I	1
Klaushofer, K; Koller, B; Muschitz, C; Patsch, J; Pollhammer, I; Resch, H; Roschger, P	1
Mukherjee, S; Oldfield, E; Song, Y	1
Abelson, A	1
Liu, RH; Werth, VP	1
Silverman, SL	1
Lomashvili, KA; Malluche, HH; Monier-Faugere, MC; O'Neill, WC; Wang, X	1
Geusens, P	1
D'Haese, PC; De Broe, ME; Neven, EG	1
Endo, Y; Funayama, H; Kawamura, H; Kumamoto, H; Kuroishi, T; Oizumi, T; Sasaki, K; Sugawara, S; Takahashi, H; Yamaguchi, K; Yamamoto, M; Yokoyama, M	1
Henry, C; Jahnke, W	1
Markovic, L; Pejnovic, N; Vujasinovic-Stupar, N; Zlatanovic, M	1
Clark, OA; Djulbegovic, B; Glasmacher, A; Kumar, A; Mhaskar, R; Miladinovic, B; Redzepovic, J; Wheatley, K	1
Chen, M; Chen, Y; Chen, Z; Liu, Y; Zhu, Y	1
Ben-Aharon, I; Rizel, S; Shpilberg, O; Stemmer, SM; Sulkes, A; Vidal, L; Yerushalmi, R	1
Elahian, F; Lage, H; Mansouri, M; Mirzaei, SA; Mousavi, SS	1
Chikazu, D; Hamada, H; Koizumi, T; Matsuo, A; Satomi, T	1
Arponen, H; Haukka, J; Mäkitie, O; Valta, H; Vuorimies, I; Waltimo-Sirén, J	1
Djulbegovic, B; Kumar, A; Mhaskar, R; Miladinovic, B	1
Chowdhury, A; Karamched, SR; Nosoudi, N; Parasaram, V; Parrish, J; Siclari, S	1
Adams, A; Heidenreich, A; Jakob, T; Kuhr, K; Macherey, S; Monsef, I; Skoetz, N; Tesfamariam, YM	1

Reviews

40 review(s) available for etidronate and pamidronate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Bisphosphonates, Old Friends of Bones and New Trends in Clinics. Journal of medicinal chemistry, 2021, 02-11, Volume: 64, Issue:3 Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Drug Compounding; Drug Delivery Systems; Humans	2021
Bone metastases and tumor-induced hypercalcemia. Current opinion in oncology, 1992, Volume: 4, Issue:4 Topics: Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Calcitonin; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hypocalcemia; Osteoclasts; Osteolysis; Pain; Pamidronate; Strontium Radioisotopes	1992
[Diphosphonates in the treatment of osteoporosis]. Nederlands tijdschrift voor geneeskunde, 1991, Mar-30, Volume: 135, Issue:13 Topics: Aged; Diphosphonates; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate	1991
Hypercalcemia and bone metastases in breast cancer. Current opinion in oncology, 1990, Volume: 2, Issue:6 Topics: Alendronate; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Hypercalcemia; Neoplasm Proteins; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factors	1990
Bone metastases and breast cancer. Cancer treatment reviews, 1985, Volume: 12, Issue:4 Topics: Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium-Binding Proteins; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Lymphokines; Osteocalcin; Osteogenesis; Pamidronate; Peptides; Prostaglandin Antagonists; Prostaglandins; Tomography, X-Ray Computed; Transforming Growth Factors	1985
Dynamic radiologic patterns of Paget's disease of bone. Clinical orthopaedics and related research, 1987, Issue:217 Topics: Biomechanical Phenomena; Bone and Bones; Bone Development; Bone Resorption; Calcitonin; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Radiography; Time Factors	1987
[Biphosphonate as a therapeutic drug--experimental studies and clinical application]. Therapeutische Umschau. Revue therapeutique, 1985, Volume: 42, Issue:6 Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Myositis Ossificans; Osteitis Deformans; Osteolysis; Osteoporosis; Pamidronate; Urinary Calculi	1985
[Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis]. Acta haematologica Polonica, 1994, Volume: 25, Issue:2 Topics: Bone Neoplasms; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasms; Osteolysis; Osteosclerosis; Pamidronate	1994
Update on the medical treatment of hypercalcemia of malignancy. Clinical pharmacy, 1993, Volume: 12, Issue:2 Topics: Animals; Antineoplastic Agents; Calcitonin; Diphosphonates; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Treatment Outcome	1993
Newer agents for the treatment of malignant hypercalcemia. The American journal of the medical sciences, 1993, Volume: 305, Issue:6 Topics: Diphosphonates; Etidronic Acid; Gallium; Humans; Hypercalcemia; Neoplasms; Pamidronate	1993
Pathogenesis and management of cancer associated hypercalcaemia. Cancer surveys, 1994, Volume: 21 Topics: Antineoplastic Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Diuretics; Etidronic Acid; Fluid Therapy; Gallium; Humans; Hypercalcemia; Neoplasms; Pamidronate; Phosphates; Plicamycin; Research	1994
Bisphosphonate therapy. The American journal of the medical sciences, 1997, Volume: 313, Issue:1 Topics: Alendronate; Animals; Bone Density; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid	1997
Use of bisphosphonates in cancer patients. Cancer treatment reviews, 1996, Volume: 22, Issue:4 Topics: Alendronate; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Pain; Pamidronate; Structure-Activity Relationship	1996
Bisphosphonates: preclinical aspects and use in osteoporosis. Annals of medicine, 1997, Volume: 29, Issue:1 Topics: Alendronate; Animals; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteoporosis; Pamidronate	1997
Bisphosphonates in multiple myeloma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Bone Diseases; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Multiple Myeloma; Pain; Pamidronate; Randomized Controlled Trials as Topic	1997
Bisphosphonates and breast carcinoma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Bone Diseases; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcification, Physiologic; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Pain; Pamidronate; Treatment Outcome	1997
Management of male osteoporosis: report of the UK Consensus Group. QJM : monthly journal of the Association of Physicians, 1998, Volume: 91, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Diphosphonates; Etidronic Acid; Glucocorticoids; Humans; Hypogonadism; Male; Middle Aged; Osteoporosis; Pamidronate; Risk Factors; Testosterone; Transplantation	1998
Aredia: the once-monthly infusion for the treatment of bone metastases. Current opinion in oncology, 1998, Volume: 10 Suppl 1 Topics: Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Humans; Male; Multiple Myeloma; Osteoclasts; Pamidronate; Randomized Controlled Trials as Topic	1998
The role of bisphosphonates for the treatment of bone disease in multiple myeloma. Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6 Topics: Adult; Aged; Aged, 80 and over; Bone Remodeling; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hypercalcemia; Male; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Osteolysis; Palliative Care; Pamidronate; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome	1998
Bisphosphonates as cancer drugs. Hospital practice (1995), 1999, May-15, Volume: 34, Issue:5 Topics: Antineoplastic Agents; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasm Proteins; Neoplasms; Osteolysis; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Risedronic Acid; Transforming Growth Factor beta	1999
Oral bisphosphonates: A review of clinical use in patients with bone metastases. Cancer, 2000, Jan-01, Volume: 88, Issue:1 Topics: Alendronate; Biological Availability; Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Multiple Myeloma; Pamidronate; Prostatic Neoplasms; Pyridines; Randomized Controlled Trials as Topic; Risedronic Acid; Zoledronic Acid	2000
Bisphosphonates in multiple myeloma. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Suppl Topics: Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Pain; Pamidronate	2000
Bisphosphonates in the treatment of osteoporosis. Principles and efficacy. Annales de medecine interne, 2000, Volume: 151, Issue:6 Topics: Administration, Oral; Alendronate; Animals; Bone and Bones; Bone Density; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Diphosphonates; Etidronic Acid; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Papio; Prospective Studies; Randomized Controlled Trials as Topic; Risedronic Acid; Spinal Fractures; Time Factors	2000
Treatment of osteoporosis with bisphosphonates. Rheumatic diseases clinics of North America, 2001, Volume: 27, Issue:1 Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid	2001
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. La Revue de medecine interne, 2001, Volume: 22, Issue:7 Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematologic Neoplasms; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Prognosis; Recurrence; Sodium Chloride; Treatment Outcome; Zoledronic Acid	2001
Bisphosphonates for the relief of pain secondary to bone metastases. The Cochrane database of systematic reviews, 2002, Issue:2 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Pain; Pamidronate; Randomized Controlled Trials as Topic	2002
Treatment of hypercalcemia of malignancy with bisphosphonates. Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 21 Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2002
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications. Oncology, 2005, Volume: 68, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clodronic Acid; Diphosphonates; Etidronic Acid; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Imidazoles; Lung Neoplasms; Pamidronate; Positron-Emission Tomography; Predictive Value of Tests; Therapeutic Equivalency; Zoledronic Acid	2005
[Pharmacological treatment of osteitis deformans (Paget's bone disease)]. Ugeskrift for laeger, 2005, Feb-28, Volume: 167, Issue:9 Topics: Alendronate; Analgesics, Non-Narcotic; Antimetabolites; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Risedronic Acid	2005
[Paget's disease and its therapeutic management]. Presse medicale (Paris, France : 1983), 2005, Apr-23, Volume: 34, Issue:8 Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Diphosphonates; Etidronic Acid; Follow-Up Studies; Humans; Infusions, Intravenous; Osteitis Deformans; Pamidronate; Remission Induction; Risedronic Acid; Time Factors; Treatment Outcome	2005
Fracture prevention in postmenopausal women. Clinical evidence, 2006, Issue:15 Topics: Aged; Alendronate; Bone Density Conservation Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Spontaneous; Hormone Replacement Therapy; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Pamidronate; Parathyroid Hormone; Risedronic Acid; Selective Estrogen Receptor Modulators; Vitamin D	2006
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Current medical research and opinion, 2008, Volume: 24, Issue:3 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; Humans; Imidazoles; Middle Aged; Osteitis Deformans; Pamidronate; Risedronic Acid; Risk Factors; Treatment Outcome; Zoledronic Acid	2008
Paget disease of bone: therapeutic options. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:5 Topics: Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Retreatment; Risedronic Acid; Treatment Outcome	2008
Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. Current osteoporosis reports, 2009, Volume: 7, Issue:1 Topics: Alendronate; Animals; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Fracture Healing; Fractures, Bone; Humans; Jaw Diseases; Middle Aged; Osteonecrosis; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid	2009
Bisphosphonates in multiple myeloma: a network meta-analysis. The Cochrane database of systematic reviews, 2012, May-16, Issue:5 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Diphosphonates; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Multiple Myeloma; Pamidronate; Randomized Controlled Trials as Topic; Zoledronic Acid	2012
Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis. PloS one, 2013, Volume: 8, Issue:8 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Diphosphonates; Disease-Free Survival; Etidronic Acid; Female; Humans; Ibandronic Acid; Pamidronate; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Risedronic Acid; Risk; Treatment Outcome	2013
Bisphosphonates in multiple myeloma: an updated network meta-analysis. The Cochrane database of systematic reviews, 2017, 12-18, Volume: 12 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Diphosphonates; Disease-Free Survival; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Multiple Myeloma; Pamidronate; Randomized Controlled Trials as Topic; Spinal Fractures; Zoledronic Acid	2017
Bisphosphosphonate-calcium phosphate cement composite and its properties. Bio-medical materials and engineering, 2019, Volume: 30, Issue:3 Topics: Alendronate; Animals; Biocompatible Materials; Bone Density Conservation Agents; Calcium Phosphates; Diphosphonates; Drug Carriers; Drug Delivery Systems; Etidronic Acid; Humans; Pamidronate; Zoledronic Acid	2019
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis. The Cochrane database of systematic reviews, 2020, 12-03, Volume: 12 Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Denosumab; Diphosphonates; Etidronic Acid; Humans; Male; Network Meta-Analysis; Pamidronate; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Zoledronic Acid	2020

Trials

10 trial(s) available for etidronate and pamidronate

Article	Year
Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:1 Topics: Adult; Aged; Analysis of Variance; Calcium; Diphosphonates; Double-Blind Method; Etidronic Acid; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pamidronate	1992
Hypercalcemia and bone metastases in breast cancer. Current opinion in oncology, 1990, Volume: 2, Issue:6 Topics: Alendronate; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Hypercalcemia; Neoplasm Proteins; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factors	1990
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia. Lancet (London, England), 1989, Nov-18, Volume: 2, Issue:8673 Topics: Administration, Oral; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Drug Evaluation; Etidronic Acid; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Recurrence; Time Factors	1989
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clinical orthopaedics and related research, 1987, Issue:217 Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteitis Deformans; Pamidronate; Remission Induction; Time Factors	1987
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease. Annals of the rheumatic diseases, 1985, Volume: 44, Issue:1 Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Creatinine; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Middle Aged; Osteitis Deformans; Pamidronate	1985
Comparative study of available medical therapy for hypercalcemia of malignancy. The American journal of medicine, 1983, Volume: 74, Issue:3 Topics: Administration, Oral; Adult; Aged; Calcium; Clinical Trials as Topic; Diphosphonates; Etidronic Acid; Female; Glucocorticoids; Humans; Hypercalcemia; Hyperparathyroidism; Indomethacin; Male; Middle Aged; Neoplasms; Pamidronate; Phosphates; Plicamycin; Random Allocation; Time Factors	1983
Paget's disease of bone. British medical journal (Clinical research ed.), 1982, Jan-23, Volume: 284, Issue:6311 Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate	1982
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Calcified tissue international, 1993, Volume: 53, Issue:4 Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pain; Pamidronate	1993
Bisphosphonates in multiple myeloma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Bone Diseases; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Multiple Myeloma; Pain; Pamidronate; Randomized Controlled Trials as Topic	1997
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium	2005

Other Studies

84 other study(ies) available for etidronate and pamidronate

Article	Year
An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs. Journal of medicinal chemistry, 2002, Jul-04, Volume: 45, Issue:14 Topics: Alkyl and Aryl Transferases; Animals; Bone Resorption; Crystallography, X-Ray; Dictyostelium; Diphosphonates; Enzyme Inhibitors; Geranyltranstransferase; Humans; Inhibitory Concentration 50; Models, Molecular; Quantitative Structure-Activity Relationship; Rats	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase. Proceedings of the National Academy of Sciences of the United States of America, 2007, Jul-24, Volume: 104, Issue:30 Topics: Crystallography, X-Ray; Diphosphonates; DNA Nucleotidyltransferases; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Microbial Viability; Models, Molecular; Protein Structure, Tertiary	2007
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters. ACS medicinal chemistry letters, 2015, Apr-09, Volume: 6, Issue:4 Topics:	2015
Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro. Bone, 1992, Volume: 13, Issue:3 Topics: Alkaline Phosphatase; Animals; Bone and Bones; Chick Embryo; Culture Techniques; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Osteoblasts; Osteogenesis; Pamidronate; Periosteum	1992
Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:8 Topics: Animals; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Neoplasms; Pamidronate	1991
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991, Volume: 6, Issue:9 Topics: Alendronate; Animals; Benzoates; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Ibandronic Acid; Injections, Intravenous; Osteoclasts; Pamidronate; Rats; Retinoids; Risedronic Acid; Spectrophotometry, Atomic; Tetracycline; Thyroxine	1991
Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice. Cancer, 1991, Feb-01, Volume: 67, Issue:3 Topics: Alendronate; Animals; Diphosphonates; Etidronic Acid; Female; Mice; Mice, Inbred C3H; Necrosis; Neoplasm Transplantation; Osteolysis; Pamidronate; Radiography; Skull; Urinary Bladder Neoplasms	1991
[Diphosphonates in the treatment of osteoporosis]. Therapeutische Umschau. Revue therapeutique, 1991, Volume: 48, Issue:2 Topics: Bone Density; Diphosphonates; Etidronic Acid; Female; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate	1991
Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. The Journal of clinical investigation, 1990, Volume: 85, Issue:2 Topics: Animals; Bone Resorption; Cells, Cultured; Chickens; Diphosphonates; Etidronic Acid; Female; Osteoclasts; Pamidronate; Proline	1990
Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1990, Volume: 5, Issue:1 Topics: Alendronate; Animals; Bone Resorption; Cattle; Cell Survival; Diphosphonates; Etidronic Acid; In Vitro Techniques; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microscopy, Polarization; Osteoclasts; Pamidronate; Rats; Rats, Inbred Strains; Video Recording	1990
Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice. The Journal of urology, 1990, Volume: 144, Issue:3 Topics: Adenocarcinoma; Alendronate; Animals; Diphosphonates; Etidronic Acid; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Osteolysis; Pamidronate; Prostatic Neoplasms	1990
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment. Nuclear medicine communications, 1990, Volume: 11, Issue:11 Topics: Aged; Aged, 80 and over; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Retrospective Studies; Scotland; Technetium Tc 99m Medronate	1990
Comparison of the distribution of three bisphosphonates in mice. Pharmacology & toxicology, 1990, Volume: 66, Issue:4 Topics: Animals; Clodronic Acid; Diphosphonates; Etidronic Acid; Injections, Intravenous; Male; Mice; Pamidronate; Tissue Distribution	1990
[Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate]. Revue du rhumatisme et des maladies osteo-articulaires, 1989, Mar-15, Volume: 56, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Diphosphonates; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate	1989
Effects of intracellular diphosphonates on cells of the mononuclear phagocyte system: in vivo effects of liposome-encapsulated diphosphonates on different macrophage subpopulations in the spleen. Calcified tissue international, 1989, Volume: 45, Issue:3 Topics: Animals; Diphosphonates; Drug Carriers; Etidronic Acid; Female; Liposomes; Macrophages; Mice; Mice, Inbred Strains; Pamidronate; Phagocytes; Spleen	1989
Diphosphonates inhibit human osteoblast secretion and proliferation. Metabolism: clinical and experimental, 1989, Volume: 38, Issue:2 Topics: Alkaline Phosphatase; Calcitriol; Cell Division; Cells, Cultured; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Kinetics; Osteoblasts; Pamidronate; Thymidine	1989
'Breaking the back' of Paget's bone disease. Archives of internal medicine, 1989, Volume: 149, Issue:12 Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Plicamycin	1989
Bisphosphonates can reduce osteoclastic bone resorption by two different mechanisms. Advances in experimental medicine and biology, 1986, Volume: 208 Topics: Animals; Bone and Bones; Bone Resorption; Cell Differentiation; Chemotaxis; Clodronic Acid; Culture Techniques; Diphosphonates; Etidronic Acid; Female; Liver; Metacarpus; Mice; Osteoclasts; Pamidronate; Pregnancy; Radius	1986
Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro. Bone, 1987, Volume: 8, Issue:3 Topics: Animals; Bone and Bones; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; In Vitro Techniques; Kinetics; Lysosomes; Mice; Minerals; Mitosis; Pamidronate; Parathyroid Hormone; Protein Biosynthesis	1987
Ultrastructural effects of diphosphonates on dental enamel. Advances in dental research, 1987, Volume: 1, Issue:2 Topics: Clodronic Acid; Dental Enamel; Diphosphonates; Etidronic Acid; Humans; Pamidronate; Surface Properties	1987
The effect of anti-rheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation. Agents and actions, 1986, Volume: 19, Issue:1-2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage; Culture Techniques; Diphosphonates; Etidronic Acid; Hydrocortisone; Pamidronate; Swine; Synovial Membrane	1986
Treating Paget's disease. British medical journal (Clinical research ed.), 1987, Jun-06, Volume: 294, Issue:6585 Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate	1987
Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD. The British journal of radiology, 1987, Volume: 60, Issue:717 Topics: Aged; Diphosphonates; Etidronic Acid; Female; Femur; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography; Skull; Tibia; Time Factors	1987
Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups. The Annals of thoracic surgery, 1988, Volume: 46, Issue:3 Topics: Aldehydes; Animals; Aortic Valve Stenosis; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Disease Models, Animal; Electrons; Etidronic Acid; Glutaral; Heart Valve Prosthesis; Male; Pamidronate; Rats; Rats, Inbred Strains; Time Factors	1988
Diphosphonates for otospongiosis. The American journal of otology, 1985, Volume: 6, Issue:1 Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Male; Mandible; Mandibular Diseases; Middle Aged; Osteitis Deformans; Otosclerosis; Pamidronate	1985
In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. Immunology, 1982, Volume: 47, Issue:1 Topics: Cell Division; Cells, Cultured; Clodronic Acid; Diphosphonates; DNA; Dose-Response Relationship, Drug; Etidronic Acid; Humans; Lymphocyte Activation; Lymphocytes; Pamidronate; Phagocytes; Pokeweed Mitogens	1982
Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer research, 1984, Volume: 44, Issue:7 Topics: Animals; Bone and Bones; Bone Resorption; Carcinoma 256, Walker; Clodronic Acid; Diphosphonates; Etidronic Acid; Male; Osteoclasts; Pamidronate; Rats; Rats, Inbred Strains	1984
[Diphosphonates in the treatment of hypercalcemia]. La Revue de medecine interne, 1984, Volume: 5, Issue:4 Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Pamidronate	1984
Treatment of Paget's bone disease with the bisphosphonate APD. Henry Ford Hospital medical journal, 1983, Volume: 31, Issue:4 Topics: Aged; Alkaline Phosphatase; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate	1983
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate). Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:6 Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Time Factors	1984
APD in Paget's disease of bone. Role of the mononuclear phagocyte system? Arthritis and rheumatism, 1980, Volume: 23, Issue:10 Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Lymphocyte Activation; Osteitis Deformans; Pamidronate; Phagocytes; Rats; Zinc	1980
Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. Science (New York, N.Y.), 1981, Sep-25, Volume: 213, Issue:4515 Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcium; Cholesterol; Diet, Atherogenic; Diphosphonates; Etidronic Acid; Lanthanum; Macaca fascicularis; Pamidronate	1981
Treatment of Paget's disease of bone with bisphosphonates. Revue du rhumatisme (English ed.), 1995, Volume: 62, Issue:2 Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate	1995
Tracer flows and 'difficult' organs. Nuclear medicine communications, 1995, Volume: 16, Issue:1 Topics: Bone and Bones; Diphosphonates; Etidronic Acid; Humans; Kidney; Kinetics; Models, Biological; Models, Theoretical; Organ Specificity; Osteitis Deformans; Pamidronate; Regional Blood Flow; Tomography, Emission-Computed	1995
Effects of bisphosphonates APD and HEBP on bone metabolism in vitro. Bone, 1995, Volume: 16, Issue:4 Suppl Topics: Alkaline Phosphatase; Animals; Autoradiography; Bone Development; Cell Division; Chickens; Collagen; Culture Techniques; Diphosphonates; Drug Synergism; Etidronic Acid; Glycerophosphates; Osteogenesis; Pamidronate; Periosteum	1995
Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models. Bone, 1995, Volume: 16, Issue:2 Topics: Alendronate; Animals; Autoradiography; Bone and Bones; Bone Resorption; Calcium; Carbon Radioisotopes; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Etidronic Acid; Hydroxycholecalciferols; Hypercalcemia; Male; Organ Culture Techniques; Osteoclasts; Pamidronate; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Tibia; Tissue Distribution	1995
Extensive personal experience: Paget's disease of bone. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:2 Topics: Animals; Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pain; Pamidronate; Radiography; Salmon	1995
Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. Journal of drug targeting, 1994, Volume: 2, Issue:4 Topics: Animals; Calcium; Cell Division; Cell Line; Chlorocebus aethiops; Clodronic Acid; Delayed-Action Preparations; Diphosphonates; Drug Carriers; Etidronic Acid; Humans; Kidney; Leukemia; Liposomes; Macrophages; Mice; Pamidronate; Phagocytes; Tumor Cells, Cultured	1994
Human neutrophil priming: chemiluminescence modified by hydroxyapatite and three bisphosphonates in vitro. Journal of clinical & laboratory immunology, 1993, Volume: 40, Issue:2 Topics: Adult; Clodronic Acid; Diphosphonates; Durapatite; Etidronic Acid; Humans; Luminescent Measurements; Neutrophil Activation; Neutrophils; Pamidronate; Peroxidase	1993
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. The Journal of clinical investigation, 1993, Volume: 91, Issue:5 Topics: Alendronate; Animals; Animals, Newborn; Bone Resorption; Cell Line; Cells, Cultured; Clodronic Acid; Culture Media, Conditioned; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Ibandronic Acid; Kinetics; Osteoblasts; Pamidronate; Parathyroid Hormone; Rats; Rats, Wistar; Time Factors	1993
Protective effects of disodium etidronate and pamidronate against the biomechanical repercussion of betamethasone-induced osteopenia in growing rat femurs. Bone and mineral, 1993, Volume: 20, Issue:3 Topics: Animals; Betamethasone; Biomechanical Phenomena; Bone Diseases, Metabolic; Diphosphonates; Etidronic Acid; Femur; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Pamidronate; Rats; Rats, Inbred Strains	1993
Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity. Biomaterials, 1993, Volume: 14, Issue:5 Topics: Alkaline Phosphatase; Animals; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Etidronic Acid; Glutaral; Hydrolysis; Male; Metals; Microscopy, Electron; Pamidronate; Pericardium; Rats; Rats, Sprague-Dawley; Spectrophotometry, Atomic	1993
Therapeutic strategy in Paget's disease of bone. Bone, 1995, Volume: 17, Issue:5 Suppl Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone and Bones; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography; Risk Assessment; Skull	1995
Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits. The Journal of laboratory and clinical medicine, 1996, Volume: 127, Issue:2 Topics: Analysis of Variance; Animals; Aorta; Aortic Valve; Arteriosclerosis; Carbon Radioisotopes; Clodronic Acid; Diphosphonates; Etidronic Acid; Male; Mitral Valve; Muscle, Smooth, Vascular; Pamidronate; Rabbits; Reference Values; Time Factors; Tissue Distribution	1996
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer. The Canadian journal of oncology, 1995, Volume: 5 Suppl 1 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Multiple Myeloma; Osteoporosis; Pain; Pamidronate	1995
Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:10 Topics: Amines; Analysis of Variance; Animals; Binding Sites; Bone Matrix; Bone Resorption; Calcium Oxalate; Crystallization; Diphosphonates; Etidronic Acid; Female; Mice; Pamidronate; Pregnancy; Structure-Activity Relationship	1996
In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages. Journal of pharmaceutical sciences, 1997, Volume: 86, Issue:3 Topics: Animals; Bioprosthesis; Bone Resorption; Calcinosis; Carcinoma 256, Walker; Cell Line; Cell Survival; Diphosphonates; Durapatite; Etidronic Acid; Female; Macrophages; Mice; Osteolysis; Pamidronate; Rats; Rats, Wistar	1997
Nonclinical model for assessing gastric effects of bisphosphonates. Digestive diseases and sciences, 1997, Volume: 42, Issue:2 Topics: Alendronate; Animals; Chelating Agents; Diphosphonates; Edetic Acid; Egtazic Acid; Etidronic Acid; Indomethacin; Male; Pamidronate; Rats; Rats, Sprague-Dawley; Risedronic Acid; Stomach	1997
[Bisphosphonate therapy in corticoid-induced osteoporosis]. Deutsche medizinische Wochenschrift (1946), 1997, Oct-02, Volume: 122, Issue:40 Topics: Adrenal Cortex Hormones; Calcium; Diphosphonates; Drug Therapy, Combination; Estrogens; Etidronic Acid; Female; Humans; Hydroxycholecalciferols; Osteoporosis; Pamidronate; Postmenopause; Progestins; Time Factors; Vitamin D	1997
Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1998, Volume: 13, Issue:2 Topics: Amines; Animals; Bone Density; Bone Resorption; Dictyostelium; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Female; Hindlimb; Mice; Pamidronate; Structure-Activity Relationship	1998
Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1 Topics: Alendronate; Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Diphosphonates; Etidronic Acid; Female; Ovariectomy; Pamidronate; Rats; Rats, Sprague-Dawley	1998
Transformation of bisphosphonates into insoluble material in human blood in vitro. Methods and findings in experimental and clinical pharmacology, 1998, Volume: 20, Issue:4 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Biotransformation; Carbon Radioisotopes; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; In Vitro Techniques; Male; Pamidronate	1998
Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacology & toxicology, 1998, Volume: 83, Issue:3 Topics: Animals; Arteries; Calcium Channel Blockers; Clodronic Acid; Diphosphonates; Drug Synergism; Etidronic Acid; Humans; Hypercalcemia; In Vitro Techniques; Male; Nifedipine; Osteoporosis; Pamidronate; Rats; Rats, Wistar; Vasoconstriction	1998
Allotype immunoglobulin enhances alkaline phosphatase activity: implications for the inflammatory response. The Journal of laboratory and clinical medicine, 1998, Volume: 132, Issue:4 Topics: Alkaline Phosphatase; Animals; Blotting, Western; Cattle; Diphosphonates; Etidronic Acid; Humans; Immunoglobulin Allotypes; Immunoglobulin G; Immunoglobulin M; Intestines; Levamisole; Pamidronate; Rabbits; Serum Albumin, Bovine; Species Specificity; Vanadates	1998
Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management. The Journal of allergy and clinical immunology, 1998, Volume: 102, Issue:4 Pt 1 Topics: Adult; Alendronate; Antineoplastic Agents; Breast Neoplasms; Clodronic Acid; Diphosphonates; Drug Hypersensitivity; Etidronic Acid; Female; Humans; Middle Aged; Pamidronate; Skin Tests; Urticaria	1998
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:11 Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone Density; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Fractures, Bone; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Osteoporosis; Pamidronate; Parathyroid Hormone; Pilot Projects; Vitamin D	1998
Pharmacokinetics of bisphosphonates in rabbits. Pharmacology & toxicology, 1999, Volume: 84, Issue:1 Topics: Animals; Clodronic Acid; Diphosphonates; Etidronic Acid; Male; Pamidronate; Rabbits; Tissue Distribution	1999
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. The Journal of clinical investigation, 1999, Volume: 104, Issue:10 Topics: Alendronate; Animals; Apoptosis; Calcitonin; Cell Line; Cells, Cultured; Dexamethasone; Diphosphonates; Etidronic Acid; Etoposide; In Situ Nick-End Labeling; Mice; Osteoblasts; Osteocytes; Pamidronate; Prednisolone; Skull; Tumor Necrosis Factor-alpha	1999
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. Skeletal radiology, 2000, Volume: 29, Issue:5 Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Follow-Up Studies; Fractures, Spontaneous; Humans; Kyphosis; Lumbar Vertebrae; Male; Osteitis Deformans; Osteomalacia; Osteoporosis; Pamidronate; Pelvic Bones; Spinal Diseases; Spinal Fractures; Thoracic Vertebrae	2000
Gastric damage in the rat with nitrogen-containing bisphosphonates depends on pH. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:9 Topics: Administration, Oral; Alendronate; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Diphosphonates; Etidronic Acid; Hydrogen-Ion Concentration; Indomethacin; Male; Pamidronate; Rats; Rats, Sprague-Dawley; Risedronic Acid; Stomach; Structure-Activity Relationship	2000
Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Digestive diseases and sciences, 2000, Volume: 45, Issue:9 Topics: Alendronate; Animals; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Gastric Mucosa; Indomethacin; Male; Pamidronate; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Risedronic Acid; Surface Properties	2000
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer research, 2000, Nov-01, Volume: 60, Issue:21 Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Antineoplastic Agents; Bone Development; Calcification, Physiologic; Cell Differentiation; Cell Division; Cells, Cultured; Chelating Agents; Collagen; Diphosphonates; Edetic Acid; Etidronic Acid; Fetus; Gene Expression; Humans; Imidazoles; Osteoblasts; Pamidronate; Proteins; Zoledronic Acid	2000
Analgesic effect of bisphosphonates in mice. Pain, 2001, Volume: 91, Issue:3 Topics: Abdomen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Gastrointestinal Motility; Male; Mice; Mice, Inbred Strains; Pain; Pain Measurement; Pamidronate; Tail	2001
Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Alendronate; Antigens; Cell Line, Transformed; Cytotoxicity, Immunologic; Diphosphonates; Etidronic Acid; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Interferon-gamma; Interleukin-2; Jurkat Cells; Lymphocyte Activation; Monocytes; Multiple Myeloma; Neoplasms; Neoplastic Stem Cells; Osteoclasts; Osteoporosis; Pamidronate; Receptors, Antigen, T-Cell, gamma-delta; Recombinant Fusion Proteins; Risedronic Acid; Structure-Activity Relationship; T-Lymphocyte Subsets; Transfection	2001
Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2001, Volume: 16, Issue:11 Topics: Animals; Calcium Channel Blockers; Calcium Channels; Cell Division; Cell Line; Cells, Cultured; Diphosphonates; Enzyme Activation; Etidronic Acid; Kinetics; Mitogen-Activated Protein Kinases; Nifedipine; Osteoblasts; Pamidronate; Phosphorylation; Rats	2001
Hypercalcemia in patients with disseminated coccidioidomycosis. The American journal of the medical sciences, 2004, Volume: 327, Issue:1 Topics: Adult; Aged; Calcium; Coccidioidomycosis; Diphosphonates; Etidronic Acid; Female; Humans; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Retrospective Studies; Vitamin D	2004
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. Calcified tissue international, 2004, Volume: 75, Issue:3 Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Tolerance; Etidronic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Parathyroid Hormone; Risedronic Acid; Treatment Outcome	2004
Differential effects of bisphosphonates on breast cancer cell lines. Cancer letters, 2007, Feb-08, Volume: 246, Issue:1-2 Topics: Alendronate; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Cyclin D1; Diphosphonates; DNA Fragmentation; Etidronic Acid; Female; Flow Cytometry; Humans; Ibandronic Acid; Imidazoles; Pamidronate; Risedronic Acid; RNA, Messenger; Zoledronic Acid	2007
Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation. Biochemical and biophysical research communications, 2006, Sep-22, Volume: 348, Issue:2 Topics: Animals; Antioxidants; Boron Compounds; Cattle; Cells, Cultured; Chondrocytes; Clodronic Acid; Diphosphonates; Edetic Acid; Etidronic Acid; Ferrous Compounds; Flow Cytometry; Hydrogen Peroxide; Lipid Peroxidation; Pamidronate; Risedronic Acid; Simvastatin; tert-Butylhydroperoxide	2006
Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine. Journal of chromatography. A, 2007, Aug-10, Volume: 1160, Issue:1-2 Topics: Alendronate; Biological Availability; Chromatography, High Pressure Liquid; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Mass Spectrometry; Pamidronate; Reference Standards	2007
High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman. Wiener medizinische Wochenschrift (1946), 2007, Volume: 157, Issue:15-16 Topics: Absorptiometry, Photon; Accidental Falls; Administration, Oral; Biopsy; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Fractures, Spontaneous; Humans; Injections, Intravenous; Lumbar Vertebrae; Middle Aged; Pamidronate; Risedronic Acid; Spinal Fractures; Thoracic Vertebrae; Time Factors; Treatment Outcome	2007
NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model. Journal of the American Chemical Society, 2008, Jan-30, Volume: 130, Issue:4 Topics: Alendronate; Biochemistry; Bone and Bones; Bone Density Conservation Agents; Crystallography, X-Ray; Diphosphonates; Etidronic Acid; Humans; Hydrogen; Imidazoles; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Pamidronate; Protein Structure, Tertiary; Risedronic Acid; Zoledronic Acid	2008
What is new in the treatment of steroid-induced osteoporosis? Seminars in cutaneous medicine and surgery, 2007, Volume: 26, Issue:4 Topics: Bone Density Conservation Agents; Calcitonin; Diphosphonates; Etidronic Acid; Glucocorticoids; Humans; Osteoporosis; Pamidronate; Teriparatide	2007
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney international, 2009, Volume: 75, Issue:6 Topics: Animals; Aortic Diseases; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcinosis; Diphosphonates; Etidronic Acid; Pamidronate; Rats; Uremia	2009
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Kidney international, 2009, Volume: 75, Issue:6 Topics: Animals; Aortic Diseases; Calcification, Physiologic; Calcinosis; Diphosphonates; Etidronic Acid; Humans; Pamidronate; Rats; Uremia	2009
Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010, Volume: 68, Issue:5 Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Ear, External; Etidronic Acid; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Inflammation Mediators; Injections, Intraperitoneal; Injections, Subcutaneous; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Necrosis; Osteonecrosis; Osteosclerosis; Pamidronate; Pravastatin; Radionuclide Imaging; Radiopharmaceuticals; Risedronic Acid; Technetium; Tibia; Time Factors; Zoledronic Acid	2010
An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem, 2010, May-03, Volume: 5, Issue:5 Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid	2010
Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome. Rheumatology international, 2012, Volume: 32, Issue:3 Topics: Adult; Back Pain; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Etidronic Acid; Female; Humans; Infant, Newborn; Live Birth; Lumbar Vertebrae; Male; Osteoporosis; Pamidronate; Pregnancy; Pregnancy Complications; Radiography	2012
[Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection]. Se pu = Chinese journal of chromatography, 2012, Volume: 30, Issue:4 Topics: Alendronate; Chromatography, Ion Exchange; Diphosphonates; Electrochemical Techniques; Etidronic Acid; Humans; Ibandronic Acid; Pamidronate; Risedronic Acid	2012
The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells. Biochimie, 2014, Volume: 99 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diphosphonates; Drug Screening Assays, Antitumor; Etidronic Acid; Female; Humans; Imidazoles; Inhibitory Concentration 50; Neoplasm Invasiveness; Pamidronate; Risedronic Acid; Zoledronic Acid	2014
A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:6 Topics: Administration, Intravenous; Administration, Oral; Alendronate; Alveolar Process; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Early Diagnosis; Etidronic Acid; Female; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Mandible; Mandibular Diseases; Middle Aged; Osteolysis; Osteosclerosis; Pamidronate; Risedronic Acid; Risk Factors; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid	2014
Cranial base pathology in pediatric osteogenesis imperfecta patients treated with bisphosphonates. Journal of neurosurgery. Pediatrics, 2015, Volume: 15, Issue:3 Topics: Adolescent; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Follow-Up Studies; Humans; Imidazoles; Infant; Kaplan-Meier Estimate; Logistic Models; Male; Osteogenesis Imperfecta; Pamidronate; Platybasia; Retrospective Studies; Risedronic Acid; Skull Base; Zoledronic Acid	2015